Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: Is the age-related gap narrowing?

Medical Journal of Australia

Volumn 193, Issue 4, 2010, Pages 217-221

  Pinkerton, Ross ^a   Wills, Rachael Anne ^b   Coory, Michael D ^c   Fraser, Christopher J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b QUEENSLAND HEALTH   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER SURVIVAL; CHILD; CLINICAL ASSESSMENT; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVAL; TREND STUDY; ADULT; AGE DISTRIBUTION; KAPLAN MEIER METHOD; LEUKEMIA; LYMPHOMA; MORTALITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AUSTRALIA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; LEUKEMIA; LYMPHOMA; YOUNG ADULT;

EID: 77956643660     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03871.x     Document Type: Article

References (26)

1. Pulte D, Gondos A, Brenner H. Trends in 5- and 10 year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst 2008; 100: 1301-1309.
2. Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030-1043.
3. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 2008; 113: 2575-2596.
4. Birch JM, Pang D, Alston RD, et al. Survival from cancer in teenagers and young adults in England, 1979-2003. Br J Cancer 2008; 99: 830-835.
5. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer 2006; 107 (7 Suppl): 1645-1655.
6. Ferrari A, Montello M, Budd T, Bleyer A. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 2008; 50 (5 Suppl): 1101-1104. (Pubitemid 351500162)
7. Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXll/E2993) trials. Pediatr Blood Cancer 2007; 48: 254-261.
8. Schiffer CA. Differences in outcome in adolescents with acute lymphoblastic leukaemia: a consequence of better regimens? Better doctors? Both? J Clin Oncol 2003; 21: 760-761.
9. Möricke A, Zimmermann M, Reiter A, et al. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin Padiatr 2005; 217: 310-320.
10. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer 2005; 103: 1457-1467.
11. Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 2009; 45: 992-1005.
12. Horner MJ, Ries LAG, Krapcho M, et al; editors. SEER Cancer Statistics Review 1975-2006. Bethesda, Md: National Cancer Institute, 2009.
13. Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005. Cancer 2009; 115: 4973-4979.
14. Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008; 112: 1646-1654.
15. Burnett A. MRC trials in acute myeloblastic luekaemia [sic]: where have we got to? Leuk Lymphoma 2007; 48: 2289-2290.
16. Fagioli F, Zecca M, Locatelli F, et al. Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission. J Pediatr Hematol Oncol 2008; 30: 575-583.
17. Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867-2873.
18. Cairo MS, Raetz E, Lim MS, et al. Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future. Pediatr Blood Cancer 2005; 45: 753-769.
19. Hochberg J, Waxman IM, Kelly KM, et al. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science. Br J Haematol 2009; 144: 24-40.
20. Pulte D, Gondos A, Brenner H. Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 2008; 168: 469-476.
21. Hoelzer D, Ludwig WD, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495-508. (Pubitemid 26030305)
22. Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-Bcell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379-391.
23. Neth O, Seidemann K, Jansen P, et al. Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Med Pediatr Oncol 2000; 35: 20-27.
24. Thomas DA, O'Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004; 104: 1624-1630.
25. Kung FH, Schwartz CL, Ferree CR, et al. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. J Pediatr Hematol Oncol 2006; 28: 362-368.
26. Herbertson RA, Evans LS, Hutchinson J, et al. Poor outcome in adolescents with high-risk Hodgkin lymphoma. Int J Oncol 2008; 33: 145-151.